Can Canopy Growth Corp. Make You a Marijuana Millionaire?

Canopy Growth Corp. (TSX:CGC) is well positioned to become a leader in the fast-growing marijuana market. Is it time to buy shares?

| More on:

The volatility for Canopy Growth Corp. (TSX:CGC) has finally come down, and long-term investors may be wondering if the stock is a buy on the recent dip. There’s no question that the company is the very well positioned to become a global leader in the emerging marijuana market. The management team is top notch and firing on all cylinders right now.

Canopy isn’t just a commodity play

Some believe that marijuana producers like Canopy are just your everyday commodity producers. While this may be true for many marijuana producers, this is definitely not the case for Canopy. The company is investing a lot of capital into R&D as well as branding.

In this regard, the company is more of a pharmaceutical play than a commodity play. Like with any pharmaceutical company, Canopy will experiment through trial and error to discover a new strain of marijuana. If the newly discovered strain is effective at treating specific ailments, then this new strain will be branded under Canopy’s brand, and a patent may be awarded.

Canopy’s fantastic management team is willing to invest a lot in branding. The company hopes to build a fantastic brand for itself that differentiates it from your typical marijuana producer. This will separate Canopy from its competition and could give the company the durable competitive advantage it needs to thrive in the fast-growing marijuana scene.

Is Canopy a safe investment right now?

There’s no question that Canopy will continue to grow at a ridiculous rate over the next few years. Marijuana sales have grown by leaps and bounds over the last year, and this momentum is expected to continue over the next few years as marijuana becomes legalized across Canada.

The stock is not for the faint of heart, as volatility is almost guaranteed to return this year. I would not recommend Canopy as a core holding, but if you’re looking for a speculative buy, then Canopy is definitely a very interesting pick.

The stock could double or triple this year depending on what kind of news is released. However, the stock could also lose half of its value or more over a very small time duration. The headline risk involved with Canopy is huge, and you should only invest in the company if you can afford to lose a majority of your investment.

There’s still a tonne of upside potential, but it might not be realized until after a nasty correction. If you decide to buy shares, make sure you buy it in increments in case the stock decides to take a sudden nosedive.

Stay smart. Stay hungry. Stay Foolish.

Fool contributor Joey Frenette has no position in any stocks mentioned.

More on Investing

monthly calendar with clock
Dividend Stocks

4.6% Dividend Yield: I’m Buying This Monthly Passive Income Stock in Bulk

With a 4.6% yield and dependable monthly payouts, this dividend stock could be a great pick for passive income seekers.

Read more »

buildings lined up in a row
Dividend Stocks

2 Top TSX Stocks for Reliable Monthly Income

These top dividend stocks have fundamentally strong businesses, resilient payouts, high yields, and monthly distributions.

Read more »

chatting concept
Dividend Stocks

What’s Going On With Telus Stock?

Telus is navigating a challenging operating environment as competition across Canada’s telecom sector has increased.

Read more »

Person holds banknotes of Canadian dollars
Dividend Stocks

1 Canadian Dividend Stock I’d Buy Right Now

In today’s cautious market, TC Energy offers dependable income and potential upside as it streamlines, cuts debt, and benefits from…

Read more »

stocks climbing green bull market
Bank Stocks

TD Bank Stock is Up a Remarkable 68% in 1 Year: Is it a Buy?

TD Bank (TSX:TD) stock is hot, but it could get even hotter next year as tailwinds persist.

Read more »

space ship model takes off
Investing

2 Superior TSX Stocks Could Triple in 5 Years

These two Canadian growth stocks look poised to rocket higher in the years to come, if they progress as expected.

Read more »

doctor uses telehealth
Tech Stocks

Ready for Healthcare AI? Put WELL Health Technologies Plus 2 More on Your Watchlist

Three Canadian companies are sound investment options as AI adoption in the healthcare sector accelerates.

Read more »

cautious investors might like investing in stable dividend stocks
Stocks for Beginners

Is Lululemon Stock a Buy After the CEO Exit?

After Lululemon’s CEO exit, is it a buy on the reset, or is Aritzia the smarter growth bet?

Read more »